PDE 4 inhibitors (Memory Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePDE 4 inhibitors (Memory Pharmaceuticals)
Drug Alias Namecognition enhancers (Memory/Roche)PDE 4 inhibitors (Memory/Roche)MEM-1091MEM-SP-1MEM-1018 +[9] 
ClassificationSmall molecules
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsSchizophreniaCognition DisordersDepression +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemory Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding AgMemory Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsSchizophreniaCognition DisordersDepression +[5] 

Other Information

ATC CodeN/A
Related LinksN/A